Business Weekly - Cambridge, UK

Pfizers new base at Chesterford Research Park near Cambridge

The research giant, Pfizer, is to establish a new research operation in Chesterford, also home to Sosei and BioFocus DPI, taking up residence in two buildings at the park.

Pfizer already has an R & D base at Granta Park at Great Abington near Cambridge which it will retain, according to a spokesperson for the company. The news has been welcomed by local economic influencers. “Pfizer’s expansion underscores the success of the region in not just attracting but keeping world-class companies here with its combination of skilled labour, excellent communications links, a good working environment and, increasingly, its reputation as a specialist biotech hub,” said director of the Greater Cambridge Partnership, Martin Garratt.
 
Dr Jeff Solomon, CEO of biotech cluster facilitator, ERBI, added: “As a committed supporter of the Cambridge region’s biotech companies, I am delighted to hear of Pfizer’s growth within the area, which demonstrates our continued pulling power and is a further indicator of the strength and attractiveness of this region for the sector.”

Pfizer will take occupation at the brand new Emmanuel Laboratory at Chesterford, together with additional space in the existing Building 17 at the Park, totalling some 4,830 sq m (52,000 sq ft).

The Emmanuel Laboratory building comprises some 3,860 sq m (41,850 sq ft) with approximately 29 metre deep footplates able to facilitate an adjacent laboratory, write-up and office space on two floors.

Newly built, the lab incorporates all the latest shell and core design requirements for R & D occupation, including multiple dedicated separate loading accesses, an autonomous, extensive plant room and separate external stores. “The Emmanuel Laboratory is a high quality product on a premier Research Park.

“It is a natural home for Pfizer’s R & D expansion within the Cambridge Cluster,” said John Granger, head of the technology team at Carter Jonas, which acted as joint agent for Morley Fund Management.

Pfizer employs approximately 100,000 people worldwide, discovering, developing, manufacturing and marketing prescription medicines to treat a diverse range of human diseases. The company has its UK business headquarters in Surrey and its European R & D headquarters in Sandwich, Kent.

Caption: (pfiz.jpg)
Building a reputation for biotech: Pfizer takes space at the new Emmanuel Laboratory, joining Sosei and BioFocus DPI at Chesterford Research Parkah